Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: Decibel | History Defined

Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand

Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.

Benzinga

Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow

Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic.

Benzinga

Decibel Receives Final TSX Venture Exchange Acceptance For AgMedica Acquisition And Debenture Conversion

Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) announced Tuesday that it has received final acceptance from the TSX Venture Exchange for its previously announced acquisition of a Canadian licensed producer of cannabis, AgMedica Bioscience Inc.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

The 20 songs that defined Slayer's career (and the stories behind them)

The ultimate guide to thrash metal titans Slayer - as told through their greatest songs

Metal Hammer

“You can almost hear The Beatles influence and the Led Zeppelin influence at the front of the song”: How Dave Mustaine channelled unlikely influences for Megdeth's Hangar 18

"These were songs that I took with me to that first band – didn’t get a chance to get them out in my second band – but my third one I did”

MusicRadar

3 Biotech Gainers to Consider

Robust demand, technological advancements, government and private investment, are fueling the biotech industry’s expansion and driving game-changing therapies and product development. With the industry anticipated to thrive, fundamentally strong biotech stocks Regeneron Pharmaceuticals (REGN), Biogen (BIIB), and United Therapeutics (UTHR) look poised for substantial gains. Keep reading.

StockNews.com

Decibel Gets IMC-GAP Certification, Its First International Export Of Cannabis Expected In H2 2022

Decibel Cannabis Company Inc. (OTCQB: DBCCF) (TSXV: DB) a premium cannabis producer, has received its certification to export its cannabis products internationally.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Decibel Reports Q1 Record Net Revenue And Adjusted EBITDA, Here Are The Details

Decibel Cannabis Company Inc. (OTCQB: DBCCF) (TSXV:DB) released its first quarter financial results for the three month period ending March 31, 2022, revealing revenue of CA$16.7 million ($13.01 million) with strong growth of 19% over Q4 2021 and 32% over Q1 2021.

Benzinga

Decibel Repays Convertible Debentures In Full With $12M In Cash

Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB: DBCCF), a premium cannabis producer, announced the cash repayment of its 9.5% convertible debentures, which had a maturity date of May 10, 2022.

Benzinga

Cannabis Movers & Shakers: Neuraxpharm, Flower One, Flowr Corp, Decibel, YourWay Cannabis, Psychemedics

As Benzinga Cannabis Capital Conference returns (April 20-21) in Miami, gathering top CEOs, investors, and leaders in the cannabis industry, let's scroll through the latest leadership changes within the space.

Benzinga

Decibel Cannabis Appoints Beer Baroness Manjit Minhas As Senior Advisor And Director Nominee

Decibel Cannabis Company Inc. (OTCQB: DBCCF) (TSXV:DB) has appointed Manjit Minhas, an entrepreneur, venture capitalist and beer baroness as a senior advisor to its board of directors until the company's upcoming annual shareholder meeting whe

Benzinga

Decibel Cannabis Reports Fourth Consecutive Month Of Record Market Share, Operational Update

Decibel Cannabis Company Inc. (NYSE: DB) (OTC: DBCCF) has provided an operational update with respect to its capital projects and announced its fourth consecutive month of record market share in February.

Benzinga

Marijuana Producer Decibel Achieves Third Consecutive Month Of Record Market Share In January

Marijuana producer Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB: DBCCF) provided an update on its recent Canadian recreational market share.

Benzinga

Decibel Therapeutics Shares Encouraging Preclinical Data From Hearing Loss Gene Therapy Programs

Decibel Therapeutics Inc (NASDAQ: DBTX) announced the presentation of preclinical data on DB-OTO, its lead gene therapy product candidate.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Decibel Closes $54M Debt Refinancing With ConnectFirst, Increases Access To Debt By $20M

Cannabis producer Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF), has closed its previously announced financing with connectFirst Credit Union Ltd. in respect of $54 million of debt capital over an initial 5-year term.

Benzinga

What To Expect From Decibel Cannabis Co. In 2022: Strategic Priorities, Financial Outlook & More

Decibel Cannabis Company Inc. (TSX-V: DB) (OTCQB: DBCCF) provided an update on its strategic priorities and 2022 financial outlook.

Benzinga

Decibel Cannabis Shares Trading Lower On Announcing Stock Option Grants

Decibel Cannabis Company Inc. (TSX-V: DB) (OTCQB: DBCCF) reported Thursday that it has granted, effective after market close on Jan. 19, 2022, some of 3.47 million stock options to certain officers and employees of the company in accordance with its stock option plan.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Regeneron Pharmaceuticals Inc

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.